Targeted ultrasound therapy offers a less invasive prostate cancer treatment designed to minimize disruption to daily life.

Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.

Performed in a single session without any surgical incisions or scarring, the treatment utilizes an advanced fusion-guided ...

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.

Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for ...

The average age of men who get diagnosed is 67.

DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today unveils at ECR 2026 the industry's most comprehensive portfolio of ...

The methods of diagnosing and treating localised prostate cancer has changed significantly in the last two decades.

Global Urology Imaging Systems Market OverviewThe global urology imaging systems market is expected to register steady growth ...

Recognising these subtle body changes can lead to an earlier diagnosis, when treatment is more likely to be successful ...

Francis Medical, Inc., a privately held medical device company, announced today the successful completion of the first commercial (non-clinical trial) procedures in Arizona using the Vanquish® Water ...